oxamniquine has been researched along with Schistosomiasis haematobia in 4 studies
Oxamniquine: An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)
oxamniquine : A racemate comprising equimolar amounts of (R)- and (S)-oxamniquine. An anthelmintic, it is administered orally for the treatment of schistomiasis caused by Schistosoma mansoni (but not by other Schistosoma species); intramuscular administration is no longer used as it causes severe pain at the injection site.
{2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl}methanol : A member of the class of quinolines that is 1,2,3,4-tetrahydroquinoline which is substituted at positions 2, 6, and 7 by (isopropylamino)methyl, hydroxymethyl, and nitro groups, respectively.
Schistosomiasis haematobia: A human disease caused by the infection of parasitic worms SCHISTOSOMA HAEMATOBIUM. It is endemic in AFRICA and parts of the MIDDLE EAST. Tissue damages most often occur in the URINARY TRACT, specifically the URINARY BLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "praziquantel was equally effective against both parasite species." | 2.66 | The effect of metrifonate in mixed Schistosoma haematobium and Schistosoma mansoni infections in humans. ( Doehring, E; Feldmeier, H; Poggensee, U, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hess, J | 1 |
| Panic, G | 1 |
| Patra, M | 1 |
| Mastrobuoni, L | 1 |
| Spingler, B | 1 |
| Roy, S | 1 |
| Keiser, J | 1 |
| Gasser, G | 1 |
| de Jonge, N | 1 |
| Schommer, G | 1 |
| Feldmeier, H | 2 |
| Krijger, FW | 1 |
| Dafalla, AA | 1 |
| Bienzle, U | 1 |
| Deelder, AM | 1 |
| Doehring, E | 1 |
| Poggensee, U | 1 |
| Creasey, AM | 1 |
| Taylor, P | 1 |
| Thomas, JE | 1 |
3 trials available for oxamniquine and Schistosomiasis haematobia
| Article | Year |
|---|---|
Mixed Schistosoma haematobium and S. mansoni infection: effect of different treatments on the serum level of circulating anodic antigen (CAA).
Topics: Animals; Antigens, Helminth; Child; Enzyme-Linked Immunosorbent Assay; Feces; Humans; Male; Oxamniqu | 1990 |
The effect of metrifonate in mixed Schistosoma haematobium and Schistosoma mansoni infections in humans.
Topics: Adolescent; Child; Clinical Trials as Topic; Feces; Humans; Lung; Male; Oxamniquine; Parasite Egg Co | 1986 |
Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren.
Topics: Adolescent; Child; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Female; Huma | 1986 |
1 other study available for oxamniquine and Schistosomiasis haematobia
| Article | Year |
|---|---|
Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium.
Topics: Animals; Anthelmintics; Chemistry, Pharmaceutical; Disease Models, Animal; Female; Male; Mice; Organ | 2017 |